- TUL Degu and Liraglutide insulin compound preparation obtained clinical approval. Date： 2023-04-26 Browse：0
-
TUL Amoxicillin Capsules (specification: 0.5g) passed the consistency evaluation of generic drugs
Recently, TUL obtained the Notice of Approval of Supplementary Drug Application for Amoxicillin Capsules (specification: 0.5g) approved and issued by NMPA, which approved this product to pass the quality and efficacy consistency evaluation of generic drugs.
Date： 2023-04-26 Browse：151
- 2022 Annual Results Announcement Date： 2023-04-20 Browse：0
-
The first cross-border drug production in the Guangdong–Hong Kong–Macao Greater Bay Area (GBA) was officially launched
Date： 2023-07-25 Browse：55
Recently, the Effervescent tablet of vitamin C produced by Zhuhai United Laboratories Co., Ltd. Zhongshan Branch, a mainland affiliated company of GBA entrusted by The United Laboratories (Hong Kong) Co., Ltd cross-border, were officially put into production,...
-
TUL was listed in the "Top 100 Chinese chemical drug enterprises in 2022"
Date： 2023-07-25 Browse：47
On June 27, 2023 Misi Society (China Medical and Health Industry Symbiosis Conference) unveiled several authoritative lists, and TUL ranked 16th in the "Top 100 list of Chinese chemical drug enterprises in 2022". Amoxicillin capsule won the award of "2023 'Th...
-
Strong return! TUL participate CPHI Shanghai 2023
Date： 2023-07-25 Browse：57
On June 19th, the World Pharmaceutical Raw Materials Exhibition CPHI2023 kicked off in Shanghai, China. As the driving force of global antibiotic APIs, TUL's APIs and intermediates sales force, led by Zheng Shunteng, senior general manager and executive direc...
-
TUL once again passed the identification of leading backbone manufacturing enterprises in Zhongshan City
Date： 2023-07-25 Browse：48
Recently, the Zhongshan Ministry of Industry and Information Technology issued the Notice on Publishing the List of Leading Backbone (Cultivated) Manufacturing Enterprises in Zhongshan City in 2022 (ZGX [2023] No. 159), and Zhuhai United Laboratories Co., Ltd...
- TUL Class 1 innovative drug UBT251 injection successfully applied for clinical application Date： 2023-07-25 Browse：12
-
TUL won the "County Health Development Contribution Award"
Date： 2023-07-25 Browse：53
On June 10, TUL won the "County Health Development Contribution Award" at the 10th China County Health Development Forum and the second "Thousand County Project" Hospital Discipline Development Strategy Summit Forum.
-
10th Anniversary of Mr. Kam Lok Choy 's Death | Missing, Remembering, and Striving!
Date： 2023-04-26 Browse：142
April 15, 2023 is the tenth anniversary of the death ofMr. Kam Lok Choy, founder of TUL. Recently, all units of TUL organized employees to hold a memorial meeting to deeply remember Mr. Kam Lok Choy.
-
TUL Chairman Mr. Tsoi Hoi Shan Visits Henan to inspect the construction progress of TUL and Muyuan Veterinary Medicine Project
Date： 2023-04-26 Browse：174
On April 12, Mr. Tsoi Hoi Shan, Chairman of the Board of Directors of TULand his delegation went to Neixiang County, Nanyang City, Henan Province to inspect the construction progress of TUL and Muyuan veterinary drug project, and visited Muyuan for exchange.
-
350-million Project construction started, acceleratedthe development potential of TUL
Date： 2023-04-26 Browse：165
Under the command of Mr. Tsoi Hoi Shan, Chairman of the Board of Directors, all production bases of TUL have increased their R&D efforts and accelerated industrial upgrading. Recently, the new construction projects of The United Animal Healthcare (Inner Mongo...
-
The results of the eighth batch of centralized procurement were announced. Piperacillin Sodium and Tazobactam Sodium for injection (4.5g) of TUL was proposed to be selected
Date： 2023-04-26 Browse：144
On March 29th, the eighth batch of national organized centralized drug procurement resulted in the proposed winning bid. This collection covers medication for common and chronic diseases such as infections, cardiovascular and cerebrovascular diseases, allergi...